The impact of radiotherapy on the hypothalamo-pituitary axis: old vs new radiotherapy techniques
Endocrine Connections · 11.08.2023 · 12 (9)
DOI: 10.1530/ec-22-0490 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrine Connections, erschienen am 11.08.2023. Verfasst von David S McLaren und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Leeds Centre for Diabetes & Endocrinology, Leeds Teaching Hospital NHS Trust, Leeds, UK. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Multimodality cancer therapy has led to remarkable improvements in survival of childhood and young adult cancer, with survival rates exceeding 85%. Such remission rates come with their own adverse sequelea or ‘late effects’. Although the cause of these late effects is multi-factorial, radiation-related adverse effects are one of the most prevalent. Hypopituitarism is a recognised complication of irradiation of brain tumours distant to the hypothalamo-pituitary (HP) axis when the axis is included within the exposed field. Much of the data concerning the development of hypopituitarism, however, relate to early forms of photon-based radiotherapy. In this narrative review, we discuss advances in individual radiotherapy techniques currently used in treating brain tumours and their theoretical benefits based primarily on dosimetric studies. Increasingly precise radiation techniques, including advances in the delivery of photons (i.e. intensity-modulated radiotherapy) and proton beam therapy, are now available options. The premise behind these newer techniques is to reduce the dose and volume of normal tissue irradiated whilst maintaining an effective radiation dose to target tissue. When treating brain tumours distant to the HP axis the expectation, based upon dosimetric studies, is that newer forms of radiotherapy will less frequently involve the HP axis in the exposed field, and where incorporated within the field it will be exposed to a lower radiotherapy dosage. Intuitively the dosimetric studies should translate into significant reductions in the prevalence of HP dysfunction. These data are promising; however, to date there are minimal robust clinical data to determine if the theoretical benefits of these newer techniques on HP dysfunction is to be realised.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology, Leeds Centre for Diabetes & Endocrinology, Leeds Teaching Hospital NHS Trust, Leeds, UK.
- Clinical Oncology, Leeds Cancer Centre, Leeds Teaching Hospital NHS Trust, Leeds, UK.
- Division of Cardiovascular and Diabetes Research, Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds, UK.
ORCID-Profile: Robert D Murray
Zitieren
APA
McLaren, D. S., Devi, A., Kyriakakis, N., Kwok-Williams, M., & Murray, R. D. (2023). The impact of radiotherapy on the hypothalamo-pituitary axis: old vs new radiotherapy techniques. Endocrine Connections, 12(9). https://doi.org/10.1530/ec-22-0490
Vancouver
McLaren DS, Devi A, Kyriakakis N, Kwok-Williams M, Murray RD. The impact of radiotherapy on the hypothalamo-pituitary axis: old vs new radiotherapy techniques. Endocrine Connections. 2023;12(9). doi:10.1530/ec-22-0490
BibTeX
@article{McLaren2023,
author = {McLaren, David S and Devi, Aarani and Kyriakakis, Nikolaos and Kwok-Williams, Michelle and Murray, Robert D},
title = {The impact of radiotherapy on the hypothalamo-pituitary axis: old vs new radiotherapy techniques},
journal = {Endocrine Connections},
year = {2023},
volume = {12},
number = {9},
doi = {10.1530/ec-22-0490}
}
EUVIMED